Detroit — Detroit, Michigan

Detroit is a clinical research site located in Detroit, Michigan, United States 48202.

Crixeo Clinical Trials Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Detroit has participated in 12 clinical trials with 2 currently active.

Therapeutic areas: Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer, Clostridium Difficile Infection (CDI).

Sponsors: Finch Research and Development LLC., Corcept Therapeutics, Rebiotix Inc..

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Detroit?

Detroit has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Detroit conducted?

Detroit has 12 clinical trials on record, with 2 currently active. Their work covers Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer, Clostridium Difficile Infection (CDI).

Is Detroit accredited by Crixeo Clinical Trials?

Detroit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Detroit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.